CONMED Corp — Director's Dealing 2023

Aug 7, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-08-01

Reporting Person: Clifford Edward A. (VP Global Manufacturing)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options To Purchase Common Stock	$118.20	2033-08-01	Common Stock (8000)		Direct
Rsus (restricted Stock Units)	$0	2033-08-01	Common Stock (2000)		Direct

Footnotes

F1: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.